Shares of PureTech Health plc (OTCMKTS:PTCHF – Get Free Report) were down 4.2% during trading on Monday . The stock traded as low as $1.53 and last traded at $1.53. 2,000 shares traded hands during trading, a decline of 95% from the average session volume of 38,795 shares. The stock had previously closed at $1.5970.
PureTech Health Price Performance
The stock has a 50-day moving average of $1.70 and a two-hundred day moving average of $1.70.
PureTech Health Company Profile
PureTech Health PLC (“PureTech”) is a clinical-stage biopharmaceutical company focused on the development of innovative medicines to address serious diseases with high unmet medical need. Founded in 2005 by Daphne Zohar and headquartered in Boston, Massachusetts with operations in both North America and Europe, PureTech applies its proprietary platforms to advance therapeutic candidates across immunology, neuroscience and lymphatic-focused indications.
The company leverages three core technology platforms—immune tolerance, gut-targeted delivery and lymphatic transport—to develop novel molecules designed for enhanced specificity and durability of effect.
Further Reading
- Five stocks we like better than PureTech Health
- AirJoule’s Kubota Deal Is a Major Validation—But the Hard Part Comes Next
- Dividend Stocks May Be the Quiet Rotation Trade Investors Are Missing Now
- Refiner Stocks Are Near Record Highs—Can Iran-Driven Margins Keep Them There?
- Verizon May Be an AI Infrastructure Stock Hiding in Plain Sight
Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.
